Skip to content
healthcare.dev
Get a free key

Alogliptin

NDC 45802-103, Alogliptin, tablet, film coated, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-103
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA022271
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALOGLIPTIN BENZOATE12.5 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
45802-103-654580201036530 TABLET, FILM COATED in 1 BOTTLE (45802-103-65)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b25f155a-1259-47c2-aa3b-7c1356e4c7f6

  • NADAC price for package 45802010365

    GET /v1/drugs/nadac/45802010365

Use it

Look up 45802-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.